Cowen and Company’s Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 FPAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-84,333
Closed -$19K 806
2022
Q3
$19K Buy
+84,333
New +$27.3K ﹤0.01% 357

Other funds holding FPAC.WS

Cowen and Company's FPAC.WS Position: Q4 2022 in Review

Cowen and Company sold out of Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (FPAC.WS) in Q4 2022, closing a stake of 84,333 shares — an estimated $19K sold.

Cowen and Company first reported a position in FPAC.WS in Q3 2022 and held it in 1 quarter. The position peaked at $19K in Q3 2022. 4 funds tracked by Wall St. Rank hold FPAC.WS as of Q4 2022.

  • Cowen and Company reported no remaining Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Cowen and Company sold 84,333 Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $19K.
  • Cowen and Company first reported a position in Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2022 and held it in 1 quarter.
  • Cowen and Company's Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $19K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.